Amplio Spine appoints TJ Jackson as Executive Vice President of Sales and Commercialization

Boca Raton, Fla., Amplio Spine, a commercial-stage medical-device company, has appointed TJ Jackson as Executive Vice President of Sales and Commercialization, effective immediately. Jackson's extensive experience in spine commercialization is expected to drive national growth for Amplio Spine's KeyLift® platform.

Jackson, who brings over 19 years of medical-device leadership experience, has worked in diverse fields including spine, interventional pain, interventional radiology, vascular, and wound care. In his new role, he will lead Amplio Spine's national commercial strategy, focusing on direct-sales leadership, distribution-network development, engagement with physicians and key opinion leaders, and ensuring revenue and performance accountability.

"TJ has spent his career building the commercial engines that turn differentiated technology into durable market presence," said Josh Lambert, Founder and CEO of Amplio Spine. "He brings a rare ability to earn physician confidence, develop high-performance field organizations, and create the accountability that converts opportunity into execution. As Amplio advances KeyLift nationally, TJ's leadership adds real operating strength to a platform and a company built to matter."

Interest in KeyLift is growing among experienced spine and interventional pain physicians, who appreciate its unique features. "KeyLift is engineered to provide a differentiated expandable interlaminar stabilization option, combining a slim insertion profile with 4 mm of controlled, in-situ distraction after the implant is seated," explained Jackson. "It is FDA-cleared as a supplemental fixation device to help achieve fusion when used with bone graft material. The system is designed to engage the lamina and create controlled distraction intended to increase foraminal and posterior disc height. With a purpose-built platform for lumbosacral anatomy, including L5, S1, KeyLift gives appropriately trained physicians a thoughtful, anatomy-conscious option across its cleared indication."

Jackson's appointment comes from his recent role as South Regional Vice President at Premia Spine, supporting the commercialization of the TOPS™ System. His leadership history also includes roles with Spinal Simplicity, Organogenesis, Cardiovascular Systems, and Medtronic/Kyphon. A six-time President's Club winner, Jackson is known for building teams, developing markets, and bringing differentiated technologies to physicians.

Amplio Spine, headquartered in Boca Raton, Florida, is a founder-led company developing technologies for spinal stabilization and supplemental fusion. Its lead platform, KeyLift®, is FDA-cleared under 510(k) K232484. Amplio is building a focused portfolio to support the evolving needs of neurosurgeons, orthopedic spine surgeons, and interventional spine and pain physicians.

"KeyLift is the type of differentiated technology and disciplined commercial opportunity that creates the foundation for a meaningful category," said Jackson. "Amplio Spine is well-positioned to support disciplined national expansion with the right commercial leadership, field execution, and distribution capability."

This appointment marks a significant step in Amplio Spine's national growth strategy, aiming to expand the KeyLift platform's presence and impact in the medical-device market.